Chuanmiao G. Xie

600 Tianhe Road
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025.

Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025.

Journal: Experimental hematology & oncology

Published: April 27, 2026

A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study.

A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: March 13, 2026

Prognostic Value of MRI-Based Treatment Response Assessment Criteria in Hepatocellular Carcinoma After Stereotactic Body Radiotherapy: A Comparative Analysis of mRECIST, LI-RADS TRA Version 2017, and LI-RADS Radiation TRA Version 2024.

Prognostic Value of MRI-Based Treatment Response Assessment Criteria in Hepatocellular Carcinoma After Stereotactic Body Radiotherapy: A Comparative Analysis of mRECIST, LI-RADS TRA Version 2017, and LI-RADS Radiation TRA Version 2024.

Journal: Journal of magnetic resonance imaging : JMRI

Published: January 08, 2026

Clinical research and medical ethics in the era of artificial intelligence

Clinical research and medical ethics in the era of artificial intelligence

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: December 29, 2025

Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial.

Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial.

Journal: Med (New York, N.Y.)

Published: October 14, 2025

A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer.

A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer.

Journal: Cell reports. Medicine

Published: July 15, 2025

Modifying node-RADS in diagnosing parotid lymph node metastasis of nasopharyngeal carcinoma.

Modifying node-RADS in diagnosing parotid lymph node metastasis of nasopharyngeal carcinoma.

Journal: European journal of radiology

Published: June 22, 2025

Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathway.

Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathway.

Journal: Cell death & disease

Published: June 12, 2025

A Clinical-Radiomic Combined Model based on Dual-Layer Spectral CT for Predicting Pathological T4 in Gastric Cancer.

A Clinical-Radiomic Combined Model based on Dual-Layer Spectral CT for Predicting Pathological T4 in Gastric Cancer.

Journal: Academic radiology

Published: March 20, 2025

Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer.

Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer.

Journal: Frontiers in immunology

Published: March 08, 2025

Targeting tumour-neuron synapses with intracavitary RNA delivery prevents glioblastoma recurrence.

Targeting tumour-neuron synapses with intracavitary RNA delivery prevents glioblastoma recurrence.

Journal: Nature biomedical engineering

Published: March 02, 2025

Reproduction outcomes and prognostic significance of pregnancy after nasopharyngeal carcinoma treatment.

Reproduction outcomes and prognostic significance of pregnancy after nasopharyngeal carcinoma treatment.

Journal: Annals of medicine

Published: February 03, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026